What Expanded Access Really Means for Patients Who Have Banked Their Tissue
Patients who have banked adipose tissue often ask a reasonable next question: does expanded access give a way to use it? This guide explains what expanded access actually is, what it is not, and why banking a person’s own tissue does not by itself open an expanded access pathway. The goal is a clear, honest […]
Dermatologist Guide: Adipose Banking, Hair Restoration, and the Skin Research Pipeline
Dermatologists are fielding more patient questions about adipose-derived stem cells, usually prompted by marketing around hair restoration and inflammatory skin conditions. This guide gives clinicians a grounded read on what the research pipeline actually contains, how banking differs from the products being studied, and how to fit a preservation service into a dermatology practice without […]
Plastic Surgeon Guide: Banking Adipose Tissue During Liposuction
Plastic surgeons who perform liposuction already access the tissue that adipose banking preserves, which makes them a natural collection partner. The questions are operational: how to divert a portion of lipoaspirate for banking, what consent and chain-of-custody require, and where the relevant state law does and does not apply. This guide walks through the workflow […]
Atopic Dermatitis and Adipose Stem Cells: What Patients Need to Know
Atopic dermatitis, the chronic inflammatory skin condition many people call eczema, can be stubborn, and patients whose symptoms resist standard options often go looking for what is next in research. Adipose-derived stem cells appear in that search, usually tied to terms like secretome and immune modulation. This guide explains what the research is genuinely studying, […]
Florida SB 1768: The Complete Physician Compliance Checklist for Stem Cell Therapy
Florida’s CS/CS/SB 1768, codified at Sections 458.3245 and 459.0127 of the Florida Statutes and enacted as Chapter 2025-185, took effect July 1, 2025. It authorizes licensed Florida physicians to perform certain stem cell therapies that are not approved by the U.S. Food and Drug Administration, but only inside a narrow set of conditions that govern […]
The Adipose-Derived Stem Cell Market in 2026: Science, Pipeline, and What It Means for Patients Who Bank Today
The adipose-derived stem cell market is one of the most active segments in regenerative medicine in 2026, driven by over four hundred active clinical trials, the December 2024 FDA approval of the first MSC-based biologic, and a growing body of published research documenting the multipotent and immunomodulatory properties of ADSCs across orthopedic, autoimmune, neurological, and […]
Who Should Bank Their Fat Stem Cells? The Ideal Patient Profile for Adipose Tissue Banking
Adipose tissue banking is most valuable for adults who are healthy enough to have the harvest procedure, motivated by a proactive approach to their long-term health, and in a life stage where preserving high-quality cells now gives them meaningful option value against the ADSC clinical trial and approval pipeline. It is not a service that […]
How to Think About the Cost of Adipose Tissue Banking: A Framework for Making the Decision
Adipose tissue banking is a cash-pay health service typically priced between $8,000 and $15,000 depending on the package, provider, and storage terms, which makes it a significant financial decision that deserves a clear-eyed evaluation framework rather than an impulse. The right way to think about banking cost is not as a medical procedure expense but […]
Adipose Tissue Banking and Longevity Medicine: Why Health-Forward Adults Are Banking Their Fat Stem Cells Now
The longevity medicine movement has given health-forward adults a framework for thinking about their biology as something to measure, optimize, and preserve, not just treat when something goes wrong. Adipose tissue banking fits directly into that framework: it is a one-time procedure that preserves your own adipose-derived stem cells at their current biological quality, for […]
Adipose-Derived Stem Cells in Neurological Conditions: What the Research Shows
Neurological conditions, including ALS, stroke recovery, spinal cord injury, Parkinson’s disease, and multiple sclerosis, represent one of the most active areas of mesenchymal stem cell research, driven by the lack of effective standard treatments for most of these conditions and the biological plausibility of MSC neuroprotective and anti-inflammatory mechanisms. The evidence base for adipose-derived stem […]
